Literature DB >> 31042115

The UIG-1/CDC-42 guanine nucleotide exchange factor acts in parallel to CED-10/Rac1 during axon outgrowth in Caenorhabditis elegans.

Wei Cao1, Shuer Deng1, Roger Pocock1.   

Abstract

During development of the brain, neuronal circuits are formed through the projection of axons and dendrites in response to guidance signals. Rho GTPases (Rac1/RhoA/Cdc42) are major regulators of axo-dendritic outgrowth and guidance due to their role in controlling actin cytoskeletal dynamics, cell adhesion and motility. Functional redundancy of Rho GTPase-regulated pathways in neuronal development can mask the roles of specific GTPases. To examine potential Rho GTPase redundancy, we utilized a recently isolated hypomorphic mutation in a Caenorhabditis elegans Rac1 protein - CED-10(G30E) - which reduces the GTP binding and inhibits axon outgrowth of the PVQ interneurons. Here, we show that the CDC-42-specific guanine nucleotide exchange factor UIG-1 acts in parallel to CED-10/Rac1 to control PVQ axon outgrowth. UIG-1 performs this function in a cell-autonomous manner. Further, we found that transgenic expression of CDC-42 can compensate for aberrant CED-10(G30E)-regulated signalling during PVQ axon outgrowth. Together, our study reveals a previously unappreciated function for CDC-42 in PVQ axon outgrowth in C. elegans.

Entities:  

Keywords:  Axon outgrowth; CDC-42; Rac; Rho GTPases; guanine nucleotide exchange factor

Mesh:

Year:  2019        PMID: 31042115      PMCID: PMC7781583          DOI: 10.1080/21541248.2019.1610302

Source DB:  PubMed          Journal:  Small GTPases        ISSN: 2154-1248


  15 in total

Review 1.  Rho GTPases in neuronal morphogenesis.

Authors:  L Luo
Journal:  Nat Rev Neurosci       Date:  2000-12       Impact factor: 34.870

2.  CDC-42 controls early cell polarity and spindle orientation in C. elegans.

Authors:  M Gotta; M C Abraham; J Ahringer
Journal:  Curr Biol       Date:  2001-04-03       Impact factor: 10.834

3.  Identification of a novel Cdc42 GEF that is localized to the PAT-3-mediated adhesive structure.

Authors:  Takao Hikita; Hiroshi Qadota; Daisuke Tsuboi; Shinichiro Taya; Donald G Moerman; Kozo Kaibuchi
Journal:  Biochem Biophys Res Commun       Date:  2005-09-16       Impact factor: 3.575

4.  The neuropathology of autism: defects of neurogenesis and neuronal migration, and dysplastic changes.

Authors:  Jerzy Wegiel; Izabela Kuchna; Krzysztof Nowicki; Humi Imaki; Jarek Wegiel; Elaine Marchi; Shuang Yong Ma; Abha Chauhan; Ved Chauhan; Teresa Wierzba Bobrowicz; Mony de Leon; Leslie A Saint Louis; Ira L Cohen; Eric London; W Ted Brown; Thomas Wisniewski
Journal:  Acta Neuropathol       Date:  2010-03-03       Impact factor: 17.088

5.  The genetics of Caenorhabditis elegans.

Authors:  S Brenner
Journal:  Genetics       Date:  1974-05       Impact factor: 4.562

6.  Integrin α PAT-2/CDC-42 signaling is required for muscle-mediated clearance of apoptotic cells in Caenorhabditis elegans.

Authors:  Hsiao-Han Hsieh; Tsung-Yuan Hsu; Hang-Shiang Jiang; Yi-Chun Wu
Journal:  PLoS Genet       Date:  2012-05-17       Impact factor: 5.917

7.  The Rac GTP exchange factor TIAM-1 acts with CDC-42 and the guidance receptor UNC-40/DCC in neuronal protrusion and axon guidance.

Authors:  Rafael S Demarco; Eric C Struckhoff; Erik A Lundquist
Journal:  PLoS Genet       Date:  2012-04-26       Impact factor: 5.917

8.  Small GTPase CDC-42 promotes apoptotic cell corpse clearance in response to PAT-2 and CED-1 in C. elegans.

Authors:  L J Neukomm; S Zeng; A P Frei; P A Huegli; M O Hengartner
Journal:  Cell Death Differ       Date:  2014-03-14       Impact factor: 15.828

9.  Distinct CED-10/Rac1 domains confer context-specific functions in development.

Authors:  Steffen Nørgaard; Shuer Deng; Wei Cao; Roger Pocock
Journal:  PLoS Genet       Date:  2018-09-28       Impact factor: 5.917

10.  Efficient gene transfer in C.elegans: extrachromosomal maintenance and integration of transforming sequences.

Authors:  C C Mello; J M Kramer; D Stinchcomb; V Ambros
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.